CN111575305B - Allene oxide synthetase, coding gene CsAOS and application thereof - Google Patents
Allene oxide synthetase, coding gene CsAOS and application thereof Download PDFInfo
- Publication number
- CN111575305B CN111575305B CN202010407410.3A CN202010407410A CN111575305B CN 111575305 B CN111575305 B CN 111575305B CN 202010407410 A CN202010407410 A CN 202010407410A CN 111575305 B CN111575305 B CN 111575305B
- Authority
- CN
- China
- Prior art keywords
- tea
- csaos
- allene oxide
- gene
- oxide synthetase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000364 Ligases Proteins 0.000 title claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 title abstract description 20
- 102000003960 Ligases Human genes 0.000 title abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims abstract description 76
- 235000013616 tea Nutrition 0.000 claims abstract description 46
- 230000014509 gene expression Effects 0.000 claims abstract description 28
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 26
- 235000020279 black tea Nutrition 0.000 claims abstract description 24
- AAEZMHSWRQVQEK-UHFFFAOYSA-N 2-methylideneoxirane Chemical compound C=C1CO1 AAEZMHSWRQVQEK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 235000009569 green tea Nutrition 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 19
- 238000005096 rolling process Methods 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 abstract description 29
- 238000000338 in vitro Methods 0.000 abstract description 21
- 239000000126 substance Substances 0.000 abstract description 20
- 108060000307 allene oxide cyclase Proteins 0.000 abstract description 19
- 230000005764 inhibitory process Effects 0.000 abstract description 15
- 108091034117 Oligonucleotide Proteins 0.000 abstract description 14
- 230000000692 anti-sense effect Effects 0.000 abstract description 14
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 abstract description 14
- 238000012545 processing Methods 0.000 abstract description 13
- 238000002474 experimental method Methods 0.000 abstract description 8
- 230000010474 transient expression Effects 0.000 abstract description 7
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 230000003044 adaptive effect Effects 0.000 abstract description 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 8
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 7
- 240000003553 Leptospermum scoparium Species 0.000 description 7
- 235000015459 Lycium barbarum Nutrition 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- MBDOYVRWFFCFHM-UHFFFAOYSA-N 2-hexenal Chemical compound CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 241000208125 Nicotiana Species 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- UYQGVDXDXBAABN-FQSPHKRJSA-N (9Z,11E,13S,15Z)-13-hydroperoxyoctadeca-9,11,15-trienoic acid Chemical compound CC\C=C/C[C@H](OO)\C=C\C=C/CCCCCCCC(O)=O UYQGVDXDXBAABN-FQSPHKRJSA-N 0.000 description 4
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 4
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 4
- BSAIUMLZVGUGKX-UHFFFAOYSA-N non-2-enal Chemical compound CCCCCCC=CC=O BSAIUMLZVGUGKX-UHFFFAOYSA-N 0.000 description 4
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- MBDOYVRWFFCFHM-SNAWJCMRSA-N 2-Hexenal Natural products CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 3
- 239000005792 Geraniol Substances 0.000 description 3
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 3
- 102000003820 Lipoxygenases Human genes 0.000 description 3
- 108090000128 Lipoxygenases Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 229940113087 geraniol Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000012165 high-throughput sequencing Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- HRHOWZHRCRZVCU-AATRIKPKSA-N (E)-hex-2-enyl acetate Chemical compound CCC\C=C\COC(C)=O HRHOWZHRCRZVCU-AATRIKPKSA-N 0.000 description 2
- BATOPAZDIZEVQF-MQQKCMAXSA-N (E,E)-2,4-hexadienal Chemical compound C\C=C\C=C\C=O BATOPAZDIZEVQF-MQQKCMAXSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- GXANMBISFKBPEX-ONEGZZNKSA-N (e)-hex-3-enal Chemical compound CC\C=C\CC=O GXANMBISFKBPEX-ONEGZZNKSA-N 0.000 description 2
- 125000006041 3-hexenyl group Chemical group 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- HKEZZWQWXWGASX-KKUMJFAQSA-N Asp-Leu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HKEZZWQWXWGASX-KKUMJFAQSA-N 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- 241000207746 Nicotiana benthamiana Species 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- BRJGUPWVFXKBQI-XUXIUFHCSA-N Pro-Leu-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRJGUPWVFXKBQI-XUXIUFHCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QZXMUPATKGLZAP-DXLAUQRQSA-N [(2S)-1-hexadecanoyloxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 QZXMUPATKGLZAP-DXLAUQRQSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012496 blank sample Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- RGACQXBDYBCJCY-ALCCZGGFSA-N cis-3-Hexenyl hexanoate Chemical compound CCCCCC(=O)OCC\C=C/CC RGACQXBDYBCJCY-ALCCZGGFSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001319 headspace solid-phase micro-extraction Methods 0.000 description 2
- NCDCLPBOMHPFCV-UHFFFAOYSA-N hexyl hexanoate Chemical compound CCCCCCOC(=O)CCCCC NCDCLPBOMHPFCV-UHFFFAOYSA-N 0.000 description 2
- 108010064894 hydroperoxide lyase Proteins 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FIJGNIAJTZSERN-DQQGJSMTSA-N monogalactosyl-diacylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC)CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O FIJGNIAJTZSERN-DQQGJSMTSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- BATOPAZDIZEVQF-UHFFFAOYSA-N sorbic aldehyde Natural products CC=CC=CC=O BATOPAZDIZEVQF-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- -1 terpene compounds Chemical class 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 1
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 1
- SATICYYAWWYRAM-VNKDHWASSA-N (E,E)-hepta-2,4-dienal Chemical compound CC\C=C\C=C\C=O SATICYYAWWYRAM-VNKDHWASSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- JYEBJTDTPNKQJG-FXQIFTODSA-N Ala-Asn-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N JYEBJTDTPNKQJG-FXQIFTODSA-N 0.000 description 1
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 1
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 1
- CNQAFFMNJIQYGX-DRZSPHRISA-N Ala-Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 CNQAFFMNJIQYGX-DRZSPHRISA-N 0.000 description 1
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 1
- QKHWNPQNOHEFST-VZFHVOOUSA-N Ala-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)N)O QKHWNPQNOHEFST-VZFHVOOUSA-N 0.000 description 1
- SAHQGRZIQVEJPF-JXUBOQSCSA-N Ala-Thr-Lys Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN SAHQGRZIQVEJPF-JXUBOQSCSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- SQKPKIJVWHAWNF-DCAQKATOSA-N Arg-Asp-Lys Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O SQKPKIJVWHAWNF-DCAQKATOSA-N 0.000 description 1
- RRGPUNYIPJXJBU-GUBZILKMSA-N Arg-Asp-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O RRGPUNYIPJXJBU-GUBZILKMSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- YKZJPIPFKGYHKY-DCAQKATOSA-N Arg-Leu-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKZJPIPFKGYHKY-DCAQKATOSA-N 0.000 description 1
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 1
- VJTWLBMESLDOMK-WDSKDSINSA-N Asn-Gln-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VJTWLBMESLDOMK-WDSKDSINSA-N 0.000 description 1
- JLNFZLNDHONLND-GARJFASQSA-N Asn-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N JLNFZLNDHONLND-GARJFASQSA-N 0.000 description 1
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 1
- WQAOZCVOOYUWKG-LSJOCFKGSA-N Asn-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(=O)N)N WQAOZCVOOYUWKG-LSJOCFKGSA-N 0.000 description 1
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 1
- ZQFRDAZBTSFGGW-SRVKXCTJSA-N Asp-Ser-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZQFRDAZBTSFGGW-SRVKXCTJSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100348341 Caenorhabditis elegans gas-1 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 1
- VNXXMHTZQGGDSG-CIUDSAMLSA-N Cys-His-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O VNXXMHTZQGGDSG-CIUDSAMLSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- SHERTACNJPYHAR-ACZMJKKPSA-N Gln-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O SHERTACNJPYHAR-ACZMJKKPSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- LURQDGKYBFWWJA-MNXVOIDGSA-N Gln-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N LURQDGKYBFWWJA-MNXVOIDGSA-N 0.000 description 1
- SGVGIVDZLSHSEN-RYUDHWBXSA-N Gln-Tyr-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O SGVGIVDZLSHSEN-RYUDHWBXSA-N 0.000 description 1
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 1
- YKBUCXNNBYZYAY-MNXVOIDGSA-N Glu-Lys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YKBUCXNNBYZYAY-MNXVOIDGSA-N 0.000 description 1
- AQNYKMCFCCZEEL-JYJNAYRXSA-N Glu-Lys-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AQNYKMCFCCZEEL-JYJNAYRXSA-N 0.000 description 1
- KXTAGESXNQEZKB-DZKIICNBSA-N Glu-Phe-Val Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 KXTAGESXNQEZKB-DZKIICNBSA-N 0.000 description 1
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 1
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 1
- OCDLPQDYTJPWNG-YUMQZZPRSA-N Gly-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN OCDLPQDYTJPWNG-YUMQZZPRSA-N 0.000 description 1
- NTOWAXLMQFKJPT-YUMQZZPRSA-N Gly-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN NTOWAXLMQFKJPT-YUMQZZPRSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 description 1
- SSFWXSNOKDZNHY-QXEWZRGKSA-N Gly-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN SSFWXSNOKDZNHY-QXEWZRGKSA-N 0.000 description 1
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 1
- ILUVWFTXAUYOBW-CUJWVEQBSA-N His-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)N)O ILUVWFTXAUYOBW-CUJWVEQBSA-N 0.000 description 1
- 101100083853 Homo sapiens POU2F3 gene Proteins 0.000 description 1
- QICVAHODWHIWIS-HTFCKZLJSA-N Ile-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N QICVAHODWHIWIS-HTFCKZLJSA-N 0.000 description 1
- NULSANWBUWLTKN-NAKRPEOUSA-N Ile-Arg-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N NULSANWBUWLTKN-NAKRPEOUSA-N 0.000 description 1
- NPROWIBAWYMPAZ-GUDRVLHUSA-N Ile-Asp-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N NPROWIBAWYMPAZ-GUDRVLHUSA-N 0.000 description 1
- SAVXZJYTTQQQDD-QEWYBTABSA-N Ile-Phe-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SAVXZJYTTQQQDD-QEWYBTABSA-N 0.000 description 1
- CIDLJWVDMNDKPT-FIRPJDEBSA-N Ile-Phe-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N CIDLJWVDMNDKPT-FIRPJDEBSA-N 0.000 description 1
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 1
- CUXRXAIAVYLVFD-ULQDDVLXSA-N Leu-Arg-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CUXRXAIAVYLVFD-ULQDDVLXSA-N 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- GLBNEGIOFRVRHO-JYJNAYRXSA-N Leu-Gln-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLBNEGIOFRVRHO-JYJNAYRXSA-N 0.000 description 1
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 1
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 1
- ZGUMORRUBUCXEH-AVGNSLFASA-N Leu-Lys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZGUMORRUBUCXEH-AVGNSLFASA-N 0.000 description 1
- MJTOYIHCKVQICL-ULQDDVLXSA-N Leu-Met-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MJTOYIHCKVQICL-ULQDDVLXSA-N 0.000 description 1
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N Leu-Phe-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 1
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 1
- YRRCOJOXAJNSAX-IHRRRGAJSA-N Leu-Pro-Lys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N YRRCOJOXAJNSAX-IHRRRGAJSA-N 0.000 description 1
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 1
- SQUFDMCWMFOEBA-KKUMJFAQSA-N Leu-Ser-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SQUFDMCWMFOEBA-KKUMJFAQSA-N 0.000 description 1
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 1
- ISSAURVGLGAPDK-KKUMJFAQSA-N Leu-Tyr-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O ISSAURVGLGAPDK-KKUMJFAQSA-N 0.000 description 1
- WXJKFRMKJORORD-DCAQKATOSA-N Lys-Arg-Ala Chemical compound NC(=N)NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CCCCN WXJKFRMKJORORD-DCAQKATOSA-N 0.000 description 1
- KZJQUYFDSCFSCO-DLOVCJGASA-N Lys-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N KZJQUYFDSCFSCO-DLOVCJGASA-N 0.000 description 1
- KEPWSUPUFAPBRF-DKIMLUQUSA-N Lys-Ile-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KEPWSUPUFAPBRF-DKIMLUQUSA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- QKXZCUCBFPEXNK-KKUMJFAQSA-N Lys-Leu-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 QKXZCUCBFPEXNK-KKUMJFAQSA-N 0.000 description 1
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 1
- MTBLFIQZECOEBY-IHRRRGAJSA-N Lys-Met-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O MTBLFIQZECOEBY-IHRRRGAJSA-N 0.000 description 1
- LOGFVTREOLYCPF-RHYQMDGZSA-N Lys-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-RHYQMDGZSA-N 0.000 description 1
- MIROMRNASYKZNL-ULQDDVLXSA-N Lys-Pro-Tyr Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MIROMRNASYKZNL-ULQDDVLXSA-N 0.000 description 1
- SBQDRNOLGSYHQA-YUMQZZPRSA-N Lys-Ser-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SBQDRNOLGSYHQA-YUMQZZPRSA-N 0.000 description 1
- MEQLGHAMAUPOSJ-DCAQKATOSA-N Lys-Ser-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O MEQLGHAMAUPOSJ-DCAQKATOSA-N 0.000 description 1
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 1
- GAELMDJMQDUDLJ-BQBZGAKWSA-N Met-Ala-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O GAELMDJMQDUDLJ-BQBZGAKWSA-N 0.000 description 1
- WYEXWKAWMNJKPN-UBHSHLNASA-N Met-Ala-Phe Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)N WYEXWKAWMNJKPN-UBHSHLNASA-N 0.000 description 1
- DJDFBVNNDAUPRW-GUBZILKMSA-N Met-Glu-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O DJDFBVNNDAUPRW-GUBZILKMSA-N 0.000 description 1
- RRIHXWPHQSXHAQ-XUXIUFHCSA-N Met-Ile-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O RRIHXWPHQSXHAQ-XUXIUFHCSA-N 0.000 description 1
- YLDSJJOGQNEQJK-AVGNSLFASA-N Met-Pro-Leu Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O YLDSJJOGQNEQJK-AVGNSLFASA-N 0.000 description 1
- 101100447658 Mus musculus Gas1 gene Proteins 0.000 description 1
- 101100447665 Mus musculus Gas2 gene Proteins 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 101100058850 Oryza sativa subsp. japonica CYP78A11 gene Proteins 0.000 description 1
- 101150059175 PLA1 gene Proteins 0.000 description 1
- 102100026466 POU domain, class 2, transcription factor 3 Human genes 0.000 description 1
- 240000000275 Persicaria hydropiper Species 0.000 description 1
- 235000017337 Persicaria hydropiper Nutrition 0.000 description 1
- AWAYOWOUGVZXOB-BZSNNMDCSA-N Phe-Asn-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 AWAYOWOUGVZXOB-BZSNNMDCSA-N 0.000 description 1
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- MYQCCQSMKNCNKY-KKUMJFAQSA-N Phe-His-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)O)N MYQCCQSMKNCNKY-KKUMJFAQSA-N 0.000 description 1
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- SRILZRSXIKRGBF-HRCADAONSA-N Phe-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N SRILZRSXIKRGBF-HRCADAONSA-N 0.000 description 1
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 1
- DSXPMZMSJHOKKK-HJOGWXRNSA-N Phe-Phe-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DSXPMZMSJHOKKK-HJOGWXRNSA-N 0.000 description 1
- NJJBATPLUQHRBM-IHRRRGAJSA-N Phe-Pro-Ser Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CO)C(=O)O NJJBATPLUQHRBM-IHRRRGAJSA-N 0.000 description 1
- ZLAKUZDMKVKFAI-JYJNAYRXSA-N Phe-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O ZLAKUZDMKVKFAI-JYJNAYRXSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- AMBLXEMWFARNNQ-DCAQKATOSA-N Pro-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]1CCCN1 AMBLXEMWFARNNQ-DCAQKATOSA-N 0.000 description 1
- UUHXBJHVTVGSKM-BQBZGAKWSA-N Pro-Gly-Asn Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UUHXBJHVTVGSKM-BQBZGAKWSA-N 0.000 description 1
- RYJRPPUATSKNAY-STECZYCISA-N Pro-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@@H]2CCCN2 RYJRPPUATSKNAY-STECZYCISA-N 0.000 description 1
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 1
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 1
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 1
- POQFNPILEQEODH-FXQIFTODSA-N Pro-Ser-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O POQFNPILEQEODH-FXQIFTODSA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 1
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 1
- OJPHFSOMBZKQKQ-GUBZILKMSA-N Ser-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO OJPHFSOMBZKQKQ-GUBZILKMSA-N 0.000 description 1
- PVDTYLHUWAEYGY-CIUDSAMLSA-N Ser-Glu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PVDTYLHUWAEYGY-CIUDSAMLSA-N 0.000 description 1
- UFKPDBLKLOBMRH-XHNCKOQMSA-N Ser-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)C(=O)O UFKPDBLKLOBMRH-XHNCKOQMSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- XERQKTRGJIKTRB-CIUDSAMLSA-N Ser-His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CN=CN1 XERQKTRGJIKTRB-CIUDSAMLSA-N 0.000 description 1
- BEAFYHFQTOTVFS-VGDYDELISA-N Ser-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N BEAFYHFQTOTVFS-VGDYDELISA-N 0.000 description 1
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- VZQRNAYURWAEFE-KKUMJFAQSA-N Ser-Leu-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VZQRNAYURWAEFE-KKUMJFAQSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- QILPDQCTQZDHFM-HJGDQZAQSA-N Thr-Gln-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QILPDQCTQZDHFM-HJGDQZAQSA-N 0.000 description 1
- ONNSECRQFSTMCC-XKBZYTNZSA-N Thr-Glu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ONNSECRQFSTMCC-XKBZYTNZSA-N 0.000 description 1
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- JMBRNXUOLJFURW-BEAPCOKYSA-N Thr-Phe-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N)O JMBRNXUOLJFURW-BEAPCOKYSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 1
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 1
- 102000007641 Trefoil Factors Human genes 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 1
- KBKTUNYBNJWFRL-UBHSHLNASA-N Trp-Ser-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 KBKTUNYBNJWFRL-UBHSHLNASA-N 0.000 description 1
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 1
- ARPONUQDNWLXOZ-KKUMJFAQSA-N Tyr-Gln-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ARPONUQDNWLXOZ-KKUMJFAQSA-N 0.000 description 1
- CKHQKYHIZCRTAP-SOUVJXGZSA-N Tyr-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O CKHQKYHIZCRTAP-SOUVJXGZSA-N 0.000 description 1
- PHKQVWWHRYUCJL-HJOGWXRNSA-N Tyr-Phe-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PHKQVWWHRYUCJL-HJOGWXRNSA-N 0.000 description 1
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 1
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 1
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 1
- VNGKMNPAENRGDC-JYJNAYRXSA-N Val-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 VNGKMNPAENRGDC-JYJNAYRXSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- PFMSJVIPEZMKSC-DZKIICNBSA-N Val-Tyr-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PFMSJVIPEZMKSC-DZKIICNBSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001361 allenes Chemical class 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010020688 glycylhistidine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108700023046 methionyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010022588 methionyl-lysyl-proline Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 210000000196 olfactory nerve Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 108010078580 tyrosylleucine Proteins 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/99—Other intramolecular oxidoreductases (5.3.99)
- C12Y503/99006—Allene-oxide cyclase (5.3.99.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/13—Plant traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of tea processing, and particularly relates to allene oxide synthetase, an encoding gene CsAOS and application thereof. Wherein the nucleotide sequence of the allene oxide synthetase gene CsAOS is shown in SEQ ID NO. 1; the amino acid sequence of the protein coded by the allene oxide synthase gene CsAOS is shown in SEQ ID NO. 2. The invention provides an allene oxide synthetase gene CsAOS which is derived from tea and related to tea aroma, and the allene oxide synthetase gene CsAOS has obvious expression difference in different adaptive black tea and green tea varieties. The invention discovers and proves that the content of volatile substances and jasmonic acid substances in tea can be obviously influenced by the expression of CsAOS through in vitro transient expression and in vitro oligonucleotide antisense inhibition experiments, and provides a new technical means for processing tea and cultivating excellent tea varieties.
Description
Technical Field
The invention belongs to the technical field of tea processing, and particularly relates to allene oxide synthetase, an encoding gene CsAOS and application thereof.
Background
The black tea is a fully fermented tea, is prepared by using proper tea tree new bud leaves as raw materials through a series of processes of withering, rolling (cutting), fermentation, drying and the like, is a main tea selling class in the international tea market, and is popular with consumers. The polyphenol substances of the tea leaves are subjected to a series of reactions such as oxidation reduction and the like in the fermentation process of the black tea, so that the color of the tea leaves is changed from green to red, and the basic characteristics and the fragrance of the 'red leaf and red soup' are formed, and the black tea has unique taste.
The tea aroma refers to the peculiar smell of tea which is sensed by people because different concentrations and proportions of odor substances influence olfactory nerves. Tea aroma is one of factors playing an important role in tea quality, a plurality of factors influencing tea aroma are provided, such as tea varieties, cultivation conditions, natural environment, processing technology, storage method and the like, and the volatile components in the tea are detected to be hundreds of types and mainly comprise aroma compounds such as aldehydes, ketones, alcohols, esters and the like. The components are combined in different proportions to form tea leaves with different flavors and types. The aroma component substances in the tea leaves are various, but the content of the aroma component substances is very little, the fresh tea leaves account for 0.001-0.05% (dry substances), and the black tea leaves account for 0.01-0.03% (dry substances).
The current research shows that the aroma substances in black tea mainly come from 3 aspects, including terpene compounds such as geraniol, compounds generated by the degradation of carotenoid such as ionone and the like, and oxidized lipid (Oxylipins) compounds generated by the lipid peroxidation of tea cell membranes. In the green leaves of most plants, Monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) account for more than 80% of the membrane lipid of the green leaves. During tea processing, the two chloroplast membrane lipids are decomposed under the action of activated phosphatase A1(PLA1) to produce alpha-Linolenic acid (18: 3), which is catalyzed by Lipoxygenase (LOX) to produce 13S-hydroperoxyl Linolenic acid (13-HPOT). 13-HPOT can produce different breakdown products under different physiological conditions or environmental stresses. On one hand, the 13-HPOT is catalyzed and decomposed into C6-C9 volatile substances by lipid hydroperoxide lyase (HPL), wherein the volatile substances comprise 3-hexenal, hexanal and the like with grass fragrance; on the other hand, 13-HPOT is converted into Oxidized Plant Dienoic Acid (OPDA) catalyzed by Allene Oxide Synthase (AOS) and Allene Oxiranyclase (AOC) in sequence, the OPDA produced in chloroplasts is transported by transporters to peroxisomes, and Jasmonic Acid (JA) is finally produced via oxidized plant dienoic acid Reductase (OPDA Reductase) and 3 times β -oxidation. JA is then methylated by JAMT to produce methyl jasmonate. (FIG. 1: synthetic route of jasmonates).
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides allene oxide synthetase, a coding gene CsAOS and application thereof, and aims to solve part of problems in the prior art or at least alleviate part of problems in the prior art.
The allene oxide synthetase gene CsAOS has the nucleotide sequence shown in SEQ ID NO.1 or the DNA sequence which is hybridized with the DNA sequence limited by SEQ ID NO.1 and encodes the protein with the same function; or DNA molecule which has more than 90% of homology with the DNA sequence limited by SEQ ID NO.1 and codes the same functional protein.
The invention also discloses an allene oxide synthetase, the amino acid sequence is shown in SEQ ID NO.2, or the sequence shown in SEQ ID NO.2 is subjected to substitution and/or deletion and/or addition of a plurality of amino acid residues, and the allene oxide synthetase has the amino acid sequence with the same protein function; or derived from the amino acid sequence shown in SEQ ID NO.2, has more than 98 percent of homology and has the same protein function.
The invention also discloses application of the allene oxide synthetase gene CsAOS in preparation and/or serving as lipoxygenase.
The invention also discloses application of the allene oxide synthetase gene CsAOS in adjusting the content of volatile substances in tea.
Further, the volatile substances in the tea leaves are at least one of heptanal, hexanal, 2-hexenal, 2, 4-hexadienal, 2, 4-heptadienal, 2-hexen-1-ol acetate, 2-ethylhexanol, benzyl alcohol, linalool, phenethyl alcohol, nonenal, nonanol, geraniol, 3-hexenyl ester hexanoic acid, 3-hexenyl ester or hexyl ester hexanoate.
The invention also discloses application of the allene oxide synthetase gene CsAOS in adjusting the content of jasmonic acid substances and/or salicylic acid in tea.
Further, the jasmonate substance is at least one of jasmonic acid, jasmonic amino acid and methyl jasmonate.
The invention also discloses application of the allene oxide synthetase gene CsAOS in adjusting the content of jasmonic acid precursor OPDA in tea.
The invention also discloses application of the allene oxide synthase gene CsAOS in screening tea varieties suitable for making green tea and/or tea varieties suitable for making black tea or black tea as a marker.
The invention also discloses application of the allene oxide synthase gene CsAOS in tea tree breeding.
The invention also discloses a method for promoting the expression of the allene oxide synthetase gene CsAOS in the tea, which comprises at least one treatment mode of withering, rolling and fermentation treatment steps of the tea.
In summary, the advantages and positive effects of the invention are:
the invention provides an allene oxide synthetase gene CsAOS derived from tea leaves and related to tea leaf aroma, and a protein coded by the allene oxide synthetase gene CsAOS has the function of an allene oxide synthetase.
According to the invention, the expression difference of the allene oxide synthase gene CsAOS in the black tea processing process is detected, so that the expression of the gene is promoted by the withering, rolling and fermentation in the black tea processing process, and the gene is shown to participate in the black tea making process.
The invention discovers and proves that the content of volatile substances and jasmonic acid substances in tea can be obviously influenced by the expression of CsAOS through in vitro transient expression and in vitro oligonucleotide antisense inhibition experiments, and provides a new technical means for processing tea and cultivating excellent tea varieties.
Drawings
FIG. 1 is a synthetic pathway for jasmonates;
FIG. 2 shows the expression difference of allene oxide synthase gene CsAOS in different tissues of Shuchazao according to an embodiment of the present invention; wherein, L1 is a leaf; l2 two blades; l3, trefoil; FL is flower; FR is fruit; s, stem; r is root; b, bud;
FIG. 3 shows the difference in expression of allene oxide synthase gene CsAOS during black tea processing according to an example of the present invention;
FIG. 4 is the expression of CsAOS in different adapted tea varieties according to an embodiment of the present invention;
FIG. 5 shows the expression level of allene oxide synthase gene CsAOS in an in vitro oligonucleotide antisense suppression experiment according to an embodiment of the present invention;
FIG. 6 shows the results of jasmonates assay 3d after oligonucleotide antisense suppression experiment in vitro according to an embodiment of the invention;
FIG. 7 shows the determination of volatile substances after 3d of antisense inhibition experiment of oligonucleotides in vitro according to an embodiment of the present invention;
FIG. 8 shows the expression level of the allene oxide synthase gene CsAOS transiently expressed in vitro according to the embodiment of the present invention;
FIG. 9 shows the results of jasmonates assay after 3d in vitro transient expression according to an embodiment of the invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail below with reference to examples, and the equipment and reagents used in the examples and test examples are commercially available without specific reference. The specific embodiments described herein are merely illustrative of the invention and are not intended to be limiting.
The invention discloses an allene oxide synthase gene CsAOS, and a coding protein and application thereof, which are shown in the following embodiments. The nucleotide sequence of the allene oxide synthetase gene CsAOS is shown as SEQ ID NO.1 in a sequence table, and the amino acid sequence is shown as SEQ ID NO.2 in the sequence table.
The materials involved in the invention:
1. tea tree samples: the Shucha early tea tree is planted in the agricultural industrial park of Yihui agricultural university of Yihui, Luyang area of Anhui province, and the leaf picking condition is 25-28 ℃.
The preparation process of the black tea mainly comprises the steps of picking, withering, rolling, fermenting and drying. The method specifically comprises the following steps: picking one bud and one leaf of Shucha early plant (in this case, a fresh leaf sample); spreading at room temperature for about 16h (withering sample after completion); firstly, lightly kneading tea leaves into a spherical shape, then heavily kneading and lightly kneading (a kneading sample is obtained after the completion); wrapping the tea leaves with gauze, fermenting at 30 deg.C for 12h (fermentation sample after completion), dispersing every 2h during fermentation period, and continuing fermentation; drying at 110 ℃ for about 15min (drying samples after completion).
Tobacco sample: the Nicotiana benthamiana (Nicotiana benthamiana) is grown in a light culture chamber at a temperature of 22-25 ℃.
2. Coli: DH5 α.
3. Carrier: pGEM-T Easy.
4. LB culture medium: weighing 10g of NaCl, 5g of yeast extract and 10g of tryptone, adding 950mL of ultrapure water, stirring and dissolving, adding water to a constant volume of 1000mL, and sterilizing for 15min by high-pressure steam to obtain an LB liquid culture medium, wherein the LB solid culture medium is obtained by adding 15g of agar powder into the LB liquid culture medium.
5. Ampicillin mother liquor (Amp +, 50 mg/ml): 0.5g ampicillin Amp was weighed, dissolved in 10mL sterile water, filtered, sterilized, and dispensed into vials for storage at-20 ℃.
6. In vitro oligonucleotide antisense inhibition buffer: centrifuging nucleotide powder (8000rpm,5min), adding 2ml of 50mMol/L sucrose solution into each tube, shaking on a vortex apparatus for several minutes, observing whether the powder is completely dissolved, stopping shaking if no particulate matter is found, obtaining in-vitro oligonucleotide antisense inhibition buffer solution (hereinafter referred to as buffer solution), transferring 250ul of buffer solution by using a liquid transfer gun, and subpackaging in a 96-well plate for later use.
Example 1 expression differences of allene oxide synthase Gene CsAOS in different tissues of Shuchazao, different tea plant varieties and during Black tea processing
1. Expression difference of allene oxide synthetase gene CsAOS in different tissues of Shuchazao
Respectively picking the roots, stems, flowers, fruits, buds, one leaf, two leaves and three leaves of Shucha early plants, and detecting the expression quantity of an allene oxide synthase gene CsAOS in each sample by adopting a high-throughput sequencing method.
2. Expression difference of allene oxide synthetase gene CsAOS in black tea processing process
Samples of black tea during picking, withering, rolling, fermentation and drying periods are respectively taken, cDNA is obtained according to the method in example 3, and fluorescent quantitative PCR detection is carried out, wherein the method comprises the following steps, and high-throughput sequencing is adopted for verification.
A forward primer: ACCTCCTTCTAAACCCACCAATC
Reverse primer: ACCAGGTGGCATGTTGGCTCTG
3. Expression differences of CsAOS of different adaptive tea tree varieties
Collecting three leaves of different tea tree varieties with adaptability, and detecting the expression quantity of allene oxide synthetase gene CsAOS in each sample by a high-throughput sequencing method.
Test results and analysis:
in FIG. 2, the expression difference of the allene oxide synthase gene CsAOS in different tissues of Shuchazao, which is higher in leaves and flowers, is shown, indicating that it has corresponding functions in these tissues.
In fig. 3, it can be seen that the expression difference of allene oxide synthase gene CsAOS during black tea processing, transcriptome data and quantitative PCR data indicate that the expression level of the gene is gradually increased from withering to fermentation, which indicates that the withering, rolling and fermentation of black tea processing promote the expression of the gene, and that the gene is involved in the black tea manufacturing process.
FIG. 4 is the expression of CsAOS in different adapted tea varieties according to an embodiment of the invention. As a result, it was found that CsAOS is expressed in a significantly higher amount in most of the varieties of tea suitable for making black tea and black tea than in the varieties of tea suitable for making green tea. Therefore, the expression level of the CsAOS gene can be used as a parameter for judging the tea plant variety to be suitable for preparing green tea and black tea.
Example 2 in vitro oligonucleotide antisense inhibition experiments
1. Designing and synthesizing oligonucleotide antisense primer according to AOS predicted sequence, and designing on websitehttp:// sfold.wadsworth.org/cgi-bin/soligo.plThe above was accomplished by the following primer sequences:
asODN001041-1 CTGTTGAGTGGTATTTTTCG
asODN001041-2 GTTGGGAGTGGAGTTTGGCT
asODN001041-3 GGGGTCCAGATAGGAGAGGA
asODN001041-4 GTATTGTGATGGCACGGGCG
2. dissolving with 80mM sucrose solution to obtain inhibition buffer solution, wherein the blank is sucrose solution;
3. a pair of bud and two leaves with basically consistent size, bright color, healthy color and no insect and disease are cut by scissors and inserted into a 96-well plate filled with buffer solution, and the tail of the bud and two leaves is ensured to be immersed into the buffer solution.
4. And putting the 96-well plate into a light incubator, and performing light culture according to the light intensity of 16 h/dark 8h, wherein the temperature of the incubator is 28 ℃.
5. And taking a treated 3d primer treatment sample and a blank sample.
Test results and analysis:
in fig. 5, it can be seen that the expression level of allene oxide synthase gene CsAOS in the antisense inhibition experiment of oligonucleotide in vitro is significantly inhibited compared with the control, and the inhibition rate is close to 2/3.
In FIG. 6, it can be seen that the jasmonic acid substances are measured after 3 days of antisense inhibition by the oligonucleotide in vitro, and it can be seen that the inhibition of CsAOS expression can significantly reduce the contents of jasmonic acid precursor OPDA and jasmonic acid substances JA, JA-Ile, etc. JA was reduced by more than 50% compared to control; and simultaneously, the content of the salicylic acid SA can be reduced.
In FIG. 7, the results of the volatiles measurements after 3 days of the in vitro oligonucleotide antisense inhibition experiments can be seen, which indicated that the in vitro inhibition of CsAOS was increased by about 18-fold and about 8-fold for heptanal, hexanal, 2-hexenal, 2, 4-hexadienal, 2-hexen-1-ol acetate, 2-ethylhexanol, benzyl alcohol, linalool, phenethyl alcohol, nonenal, nonanol, geraniol, 3-hexenyl ester hexanoic acid, 3-hexenyl ester, hexanoic acid-hexyl ester, especially hexanal, 2-hexenal, compared to the control.
Example 3 cloning and in vitro transient expression of the allene oxide synthase CsAOS Gene
1. Designing a specific primer, wherein a drawn part is a restriction enzyme cutting site, and the primer sequence is shown as SEQ ID NO.3 and SEQ ID NO. 4:
SEQ ID NO.3:TGGATCCATGGCTTTTACTTCTCTAGC BamH1
SEQ ID NO.4:CAAGCTTTCAAAAACTAGCTCTCTTGACG Hind3
2. extracting total RNA of the tea tree sample according to the instructions of the plant total RNA extraction kit and the first-strand cDNA synthesis kit, and performing reverse transcription to obtain cDNA.
3. And (3) taking the reverse transcription cDNA as a template, and amplifying by using the specific primer, wherein a PCR system comprises: 2. mu.l of forward primer, 2. mu.l of reverse primer, 2. mu.l of template, MIX 25. mu.l, ddH2O19 microliters; PCR procedure: the first step is as follows: the temperature is maintained at 94 ℃ for 5 min. The amplification procedure is pre-denaturation at 98 ℃ for 10s, annealing at 57 ℃ for 30s, extension at 68 ℃ for 1min, 35 cycles, and extension at 68 ℃ for 5min, and the obtained PCR product is stored at 4 ℃.
4. The PCR product was purified using a PCR purification kit and ligated into pGEM-T Easy followed by transformation of DH 5. alpha. for colony PCR, running gel and sequencing verification as follows. Obtaining positive colonies, obtaining a T vector (CsAOS-pGEM) containing the CsAOS gene, and obtaining the DH5 alpha escherichia coli containing the allene oxide synthetase gene CsAOS sequence.
Connection conditions are as follows: ligation was performed overnight at 4 ℃.
Transformation system:
adding the obtained ligation product into 50 mu L DH5 alpha, gently mixing uniformly, placing in ice, and carrying out ice bath for 30 min; thermally shocking at 42 deg.C in water bath for 45sec, immediately placing in ice, and ice-cooling for 3 min; adding 1mL of fresh LB culture medium, and carrying out shaking culture at 37 ℃ and 200rpm for 1 h; the cultured bacteria liquid is centrifuged, 300 mu L of supernatant is reserved, and the supernatant is re-suspended and mixed evenly, plated and cultured overnight at 37 ℃.
5. Designing a specific primer, wherein the primer sequence is shown as follows:
F:GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGCTTTTACTTCTCTAGC
R:GGGGACCACTTTGTACAAGAAAGCTGGGTTCAAAAACTAGCTCTCTTGACG
6. and (3) using the CsAOS-pGEM obtained in the step (4) as a template, using the primer obtained in the step (5) for amplification, and sequentially carrying out PCR verification, gel running verification and sequencing verification by using a homologous recombination method (Gateway technology) to construct the CsAOS-PB2GW 7. The fusion vector has a strong 35S promoter, and CsAOS-PB2GW7 is transferred into agrobacterium GV3101 by a freezing transformation method.
Transient expression of target genes
1. The recombinant strain CsAOS-PB2GW7 GV3101 and the control GV3101 obtained in the examples were selected and inoculated into 5ml of LB liquid medium (100ug/ml gentamicin, 50ug/ml spectinomycin), and shake-cultured at 28 ℃.
2.1 ml of overnight cultured Agrobacterium was transferred to 25ml of LB liquid medium (with the same antibiotic as1 added, additionally autoclaved acetosyringone added).
3. The OD600 value of the overnight culture broth was measured.
4.5000g, 15min for collection, and the cells were resuspended in a resuspension solution (10mM MgCl2,10mM 2- (N-morpholino) ethanesulfonic acid (pH5.6), 100uM acetosyringone) to give a final OD600 of 0.4.
5. Standing at room temperature for 2-3 hr, and injecting tobacco.
6. The infesting solution was filled into a 5ml syringe and the liquid was injected into tobacco leaves from the lower skin of the leaf (no cotyledons were used) by pressing the syringe back plate with the thumb. After injection, tobacco leaves are wet.
7. 3 days after injection, the injection leaves were removed for volatile and jasmonic analysis.
Test results and analysis:
in FIG. 8, the expression level of the allene oxide synthase gene CsAOS transiently expressed in vitro can be seen, and the results show that the expression level of CsAOS in transiently expressed tobacco is increased by 9 times.
FIG. 9 shows the results of jasmonates assay after 3d in vitro transient expression according to an embodiment of the invention. The results show that the content of jasmonates is obviously increased after transient expression, such as the content of JA and MeJA is increased by about 20 percent and 29 percent respectively.
Detection method related to the present invention
Volatile determination of in vitro oligonucleotide antisense inhibition samples:
1. determination of volatile matter is performed by using a headspace solid-phase microextraction (HS-SPME) method combined with a gas-phase mass spectrometry (GC-MS) (Agilent 7890A), extracting volatile matters of in-vitro oligonucleotide antisense inhibition samples and blank samples by using an extraction head containing 50/30um DVB/CAR/PDMS (Supelco), extracting at 60 ℃ for 1h, then taking out the extraction head, inserting the extraction head into a GC-MS sample inlet, desorbing for 5min, and starting an instrument to collect data.
2. GC-MS detection conditions
Chromatographic conditions are as follows: the temperature of a sample inlet is 240 ℃, the carrier gas is high-purity nitrogen, the purity is more than 99.99 percent, the flow rate is 0.8ml/min, and split-flow sample injection is not carried out; the chromatographic column model is HP-5MS quartz capillary column (60m × 0.32mm × 0.25 um); the column temperature is initially 40 deg.C, held for 3min, ramped to 90 deg.C at 2 deg.C/min, held for 5min, ramped to 160 deg.C at 3 deg.C/min, ramped to 250 deg.C at 10 deg.C/min, and held for 5 min.
Mass spectrum conditions: the ion source is an EI source, the temperature of the ion source is 230 ℃, the electron energy is 70eV, the temperature of a quadrupole rod is 150 ℃, the interface temperature is 280 ℃, the voltage of an electron multiplier is 1680V, and the scanning range m/z is 35-350 amu.
Determination of jasmonates:
the samples were ground to a powder in liquid nitrogen and extracted in the dark as follows.
Preparing an extraction buffer solution formula, wherein methanol: ddH2Acetic acid 80:19:1(V: V). Weighing about 0.1g of sample into a 2ml centrifuge tube, adding 750 μ l of the extract, mixing by inversion, and placing on ice, wherein the process is carried out under the condition of keeping out the light. Then carrying out rotary extraction for more than 16h at 4 ℃ under the condition of keeping out of the light. Centrifuging at 13000rpm for 10min at 4 deg.C, sucking supernatant, adding 750 μ l of extractive solution again, extracting at 4 deg.C in dark for more than 16h, centrifuging, and mixing the two supernatants. Filtering with 0.22um filter membrane (organic filter membrane), blowing with nitrogen gas, adding 200 μ l methanol, reversing for several times, and dissolving at 4 deg.C for 3-6 h. (this process was carried out under exclusion of light). After the lysate was centrifuged at 13000rpm for 15min at 4 ℃, 180. mu.l of the supernatant was gently aspirated into the inner cannula, and placed in a sample bottle dedicated to mass spectrometry for waiting for detection by the machine.
The hormone samples were analyzed by LC-MS, the liquid chromatograph is Shimadzu LC-20AD type, and the quantitative analysis was performed by external standard method.
The detection method comprises the following steps:
the liquid chromatography adopts a binary solvent system, and the mobile phase: the solution A was methanol, the solution B was 0.05% aqueous formic acid, and an Eclipse plus C18(5 μm,2.1 × 150mm) column was selected, the flow rate was controlled at 300uL/min, the column temperature was 30 ℃ and 10 μ L was injected per sample. Gradient elution was used with a gradient of 10% methanol starting and held for 2min, increasing gradually to 90% for 5min at 10 min. At 15.1min, methanol dropped to the initial gradient and was held for 7 min.
TABLE 1 liquid phase elution conditions for phytohormones
The mass spectrum conditions are as follows: the ion source is an electrospray ion source (ESI), the voltage of the ion source is-4.5 KV, the temperature of the ion source is 500 ℃, N2 is used as auxiliary heating gas2(50psi), atomizing gas1(60psi) and air curtain gas (30psi), and the object to be detected is in a negative ion mode. The standard mixture was separated in reverse phase liquid chromatography and quantitatively analyzed in tandem triple quadrupole mass spectrometry multiple reaction detection (MRM) mode with a scan time of 50 ms.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
Sequence listing
<110> agriculture university of Anhui
<120> allene oxide synthetase, coding gene CsAOS and application thereof
<140> 2020104074103
<141> 2020-05-14
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1572
<212> DNA
<213> nucleotide sequence (CsAOS)
<400> 1
atggctttta cttctctagc tttgccttcc ctgcaactac aattcttgac acaacggcct 60
ccaaaagtat catcaaaacc atactcaatt caccacccaa tctatgcttc cgtatccgaa 120
agaccatctg cgccacctcc tccggcgacg ccgaaaatga aacctccttc taaacccacc 180
aatcttccca ttcagaaaat cccaggaaac tatggccctc ccttaattgg tcccatcaaa 240
gacagactcg actacttcta caaccaaggc acagtcgaat tcttcaagtc tcgaagcgaa 300
aaataccact caacagtttt cagagccaac atgccacctg gtcccttcat ttcctccaac 360
cccaacgtgg tcgttcttct ggacggcaag agcttcccag tcctcttcga cgtcacaaaa 420
gtcgaaaaga aagacctctt cacagggact ttcatgccct ccaccgaact caccggtggt 480
taccgagtcc tctcctatct ggacccctcg gagcctaagc atgccaagct caagcaactc 540
atgttctttc tactcaaatc agggcgagac aaagtgatac cagagttcca ctcgagcttc 600
acagacctct tcgagaccct tgaagccgaa ctggcaagca aaggcaaagc agcatttagc 660
gatgccaatg accaggcttc tttcaatttc ttagctcggt cactcttcgg gaccaaccca 720
gccgatacca aactcggact cgacggaccc aatttgatag ccatatggat atttttccaa 780
ctggctcctt tgataaccct tggcctccca aagttggtgg aagagctact catccacact 840
tttcctctcc ctccagtact catcaaaaaa gactaccaaa gattgtacga ttttttctac 900
aactcgtcaa catccatcct cgacgaagcc gagaaaattg gcctctcccg cgaagaggct 960
tgccacaatc tcttattcgc cacgtgcttc aattccttcg gcggaatgaa aatctttttc 1020
cccagcatga tcaaatggat cggccatgct ggagccaaac tccactccca actcgccgag 1080
gagatccgat cagccgtcag atccagcggc gggaaagtga cgatggccgg gatggaacag 1140
atgccgttga tgaagtccgt agtgtacgaa tcgctgagga tcgacccgcc cgtgccatca 1200
caatacggtc gagcgaaacg ggacatggtg atagagtctc atgacgcagc gtttgaggtg 1260
aaagaagggg aaatgttatt tgggtaccaa ccatttgcga ctaaagatcc gaagatattc 1320
gagaggccgg aggagtttgt ggcggaccgg ttcgtcggag aggagggaga gaagatgttg 1380
aggcacgttc tgtggtcgaa tggaccggag accgagagca cgacggtggg aaacaagcaa 1440
tgcgcgggga aggacttcgt ggtgatggtg tcgaggttgt tgctggtgga gttgtttcta 1500
cgttatgatt cgtttgagac ggaggttggt tcttcagtta ctataacgtc cgtcaagaga 1560
gctagttttt ga 1572
<210> 2
<211> 523
<212> PRT
<213> amino acid sequence (CsAOS)
<400> 2
Met Ala Phe Thr Ser Leu Ala Leu Pro Ser Leu Gln Leu Gln Phe Leu
1 5 10 15
Thr Gln Arg Pro Pro Lys Val Ser Ser Lys Pro Tyr Ser Ile His His
20 25 30
Pro Ile Tyr Ala Ser Val Ser Glu Arg Pro Ser Ala Pro Pro Pro Pro
35 40 45
Ala Thr Pro Lys Met Lys Pro Pro Ser Lys Pro Thr Asn Leu Pro Ile
50 55 60
Gln Lys Ile Pro Gly Asn Tyr Gly Pro Pro Leu Ile Gly Pro Ile Lys
65 70 75 80
Asp Arg Leu Asp Tyr Phe Tyr Asn Gln Gly Thr Val Glu Phe Phe Lys
85 90 95
Ser Arg Ser Glu Lys Tyr His Ser Thr Val Phe Arg Ala Asn Met Pro
100 105 110
Pro Gly Pro Phe Ile Ser Ser Asn Pro Asn Val Val Val Leu Leu Asp
115 120 125
Gly Lys Ser Phe Pro Val Leu Phe Asp Val Thr Lys Val Glu Lys Lys
130 135 140
Asp Leu Phe Thr Gly Thr Phe Met Pro Ser Thr Glu Leu Thr Gly Gly
145 150 155 160
Tyr Arg Val Leu Ser Tyr Leu Asp Pro Ser Glu Pro Lys His Ala Lys
165 170 175
Leu Lys Gln Leu Met Phe Phe Leu Leu Lys Ser Gly Arg Asp Lys Val
180 185 190
Ile Pro Glu Phe His Ser Ser Phe Thr Asp Leu Phe Glu Thr Leu Glu
195 200 205
Ala Glu Leu Ala Ser Lys Gly Lys Ala Ala Phe Ser Asp Ala Asn Asp
210 215 220
Gln Ala Ser Phe Asn Phe Leu Ala Arg Ser Leu Phe Gly Thr Asn Pro
225 230 235 240
Ala Asp Thr Lys Leu Gly Leu Asp Gly Pro Asn Leu Ile Ala Ile Trp
245 250 255
Ile Phe Phe Gln Leu Ala Pro Leu Ile Thr Leu Gly Leu Pro Lys Leu
260 265 270
Val Glu Glu Leu Leu Ile His Thr Phe Pro Leu Pro Pro Val Leu Ile
275 280 285
Lys Lys Asp Tyr Gln Arg Leu Tyr Asp Phe Phe Tyr Asn Ser Ser Thr
290 295 300
Ser Ile Leu Asp Glu Ala Glu Lys Ile Gly Leu Ser Arg Glu Glu Ala
305 310 315 320
Cys His Asn Leu Leu Phe Ala Thr Cys Phe Asn Ser Phe Gly Gly Met
325 330 335
Lys Ile Phe Phe Pro Ser Met Ile Lys Trp Ile Gly His Ala Gly Ala
340 345 350
Lys Leu His Ser Gln Leu Ala Glu Glu Ile Arg Ser Ala Val Arg Ser
355 360 365
Ser Gly Gly Lys Val Thr Met Ala Gly Met Glu Gln Met Pro Leu Met
370 375 380
Lys Ser Val Val Tyr Glu Ser Leu Arg Ile Asp Pro Pro Val Pro Ser
385 390 395 400
Gln Tyr Gly Arg Ala Lys Arg Asp Met Val Ile Glu Ser His Asp Ala
405 410 415
Ala Phe Glu Val Lys Glu Gly Glu Met Leu Phe Gly Tyr Gln Pro Phe
420 425 430
Ala Thr Lys Asp Pro Lys Ile Phe Glu Arg Pro Glu Glu Phe Val Ala
435 440 445
Asp Arg Phe Val Gly Glu Glu Gly Glu Lys Met Leu Arg His Val Leu
450 455 460
Trp Ser Asn Gly Pro Glu Thr Glu Ser Thr Thr Val Gly Asn Lys Gln
465 470 475 480
Cys Ala Gly Lys Asp Phe Val Val Met Val Ser Arg Leu Leu Leu Val
485 490 495
Glu Leu Phe Leu Arg Tyr Asp Ser Phe Glu Thr Glu Val Gly Ser Ser
500 505 510
Val Thr Ile Thr Ser Val Lys Arg Ala Ser Phe
515 520
<210> 3
<211> 27
<212> DNA
<213> Artificial sequence (BamH1)
<400> 3
tggatccatg gcttttactt ctctagc 27
<210> 4
<211> 29
<212> DNA
<213> Artificial sequence (Hind3)
<400> 4
caagctttca aaaactagct ctcttgacg 29
Claims (2)
1. The application of the allene oxide synthetase gene CsAOS in screening tea varieties suitable for making green tea and/or tea varieties suitable for making black tea or black tea as a marker; the nucleotide sequence of the allene oxide synthetase gene CsAOS is shown in SEQ ID NO. 1.
2. A method for improving the expression quantity of an allene oxide synthetase gene CsAOS in tea is characterized in that: comprises at least one treatment mode of withering, rolling and fermenting tea leaves, and the nucleotide sequence of the allene oxide synthetase gene CsAOS is shown as SEQ ID NO. 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010407410.3A CN111575305B (en) | 2020-05-14 | 2020-05-14 | Allene oxide synthetase, coding gene CsAOS and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010407410.3A CN111575305B (en) | 2020-05-14 | 2020-05-14 | Allene oxide synthetase, coding gene CsAOS and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111575305A CN111575305A (en) | 2020-08-25 |
CN111575305B true CN111575305B (en) | 2022-03-15 |
Family
ID=72113621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010407410.3A Expired - Fee Related CN111575305B (en) | 2020-05-14 | 2020-05-14 | Allene oxide synthetase, coding gene CsAOS and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111575305B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305884B (en) * | 2019-08-05 | 2022-11-04 | 云南省烟草农业科学研究院 | Gene NtAIS 1 for improving jasmonic acid content of tobacco leaves and cloning method and application thereof |
CN111575254B (en) * | 2020-05-14 | 2022-03-15 | 安徽农业大学 | Lipoxygenase, encoding gene CsLOX3 and application thereof |
CN113025594B (en) * | 2021-03-04 | 2022-05-31 | 安徽农业大学 | Polypeptide, nucleic acid and application of polypeptide and nucleic acid in synthesis of geraniol |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780621B2 (en) * | 2000-05-24 | 2004-08-24 | Firmenich Sa | Guava (Psidium guajava) 13-hydroperoxide lyase and uses thereof |
CN102181458A (en) * | 2011-03-31 | 2011-09-14 | 复旦大学 | Method for increasing nicotine content in tobacco by utilizing camptotheca acuminate AOC (Allene Oxide Cyclase) gene transformation |
CN103805630A (en) * | 2012-11-12 | 2014-05-21 | 未名兴旺系统作物设计前沿实验室(北京)有限公司 | Novel plant fertility regulation structure and application thereof |
CN104293805A (en) * | 2013-07-16 | 2015-01-21 | 宁波大学 | Recombined lipoxygenase and preparation method thereof |
CN105296457A (en) * | 2015-11-25 | 2016-02-03 | 天津大学 | Method for improving stress resistance of plant by using Chinese wolfberry jasmonic acid metabolism approach important enzyme genes |
CN110724696A (en) * | 2019-11-19 | 2020-01-24 | 安徽农业大学 | Lipid hydroperoxide lyase and gene and application thereof |
CN111575259A (en) * | 2020-05-12 | 2020-08-25 | 安徽农业大学 | Ester type catechin synthetase, coding gene and application thereof |
WO2021044406A1 (en) * | 2019-09-03 | 2021-03-11 | Stockton (Israel) Ltd. | Tea tree oil for inducing systemic resistance in plants |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040010822A1 (en) * | 2002-05-10 | 2004-01-15 | Mcgonigle Brian | Hydroperoxyde lyases |
CN110305884B (en) * | 2019-08-05 | 2022-11-04 | 云南省烟草农业科学研究院 | Gene NtAIS 1 for improving jasmonic acid content of tobacco leaves and cloning method and application thereof |
CN111575254B (en) * | 2020-05-14 | 2022-03-15 | 安徽农业大学 | Lipoxygenase, encoding gene CsLOX3 and application thereof |
-
2020
- 2020-05-14 CN CN202010407410.3A patent/CN111575305B/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780621B2 (en) * | 2000-05-24 | 2004-08-24 | Firmenich Sa | Guava (Psidium guajava) 13-hydroperoxide lyase and uses thereof |
CN102181458A (en) * | 2011-03-31 | 2011-09-14 | 复旦大学 | Method for increasing nicotine content in tobacco by utilizing camptotheca acuminate AOC (Allene Oxide Cyclase) gene transformation |
CN103805630A (en) * | 2012-11-12 | 2014-05-21 | 未名兴旺系统作物设计前沿实验室(北京)有限公司 | Novel plant fertility regulation structure and application thereof |
CN104293805A (en) * | 2013-07-16 | 2015-01-21 | 宁波大学 | Recombined lipoxygenase and preparation method thereof |
CN105296457A (en) * | 2015-11-25 | 2016-02-03 | 天津大学 | Method for improving stress resistance of plant by using Chinese wolfberry jasmonic acid metabolism approach important enzyme genes |
WO2021044406A1 (en) * | 2019-09-03 | 2021-03-11 | Stockton (Israel) Ltd. | Tea tree oil for inducing systemic resistance in plants |
CN110724696A (en) * | 2019-11-19 | 2020-01-24 | 安徽农业大学 | Lipid hydroperoxide lyase and gene and application thereof |
CN111575259A (en) * | 2020-05-12 | 2020-08-25 | 安徽农业大学 | Ester type catechin synthetase, coding gene and application thereof |
Non-Patent Citations (5)
Title |
---|
Functional Characterization of An Allene Oxide Synthase Involved in Biosynthesis of Jasmonic Acid and Its Influence on Metabolite Profiles and Ethylene Formation in Tea ( Camellia sinensis) Flowers;Peng qiyuan等;《International Journal of Molecular Sciences》;20180818;ijms19082440 * |
NCBI.PREDICTED: Camellia sinensis allene oxide synthase 1, chloroplastic-like (LOC114284042), mRNA.《genbank database》.2019, * |
PREDICTED: Camellia sinensis allene oxide synthase 1, chloroplastic-like (LOC114284042), mRNA;NCBI;《genbank database》;20190305;ACCESSION NO.XM_028226917.1 * |
水曲柳丙二烯氧化物合成酶基因FmAOS序列与表达模式分析;刘春浩等;《植物生理学报》;20180520;第855-862页 * |
甜瓜CmLOX09对逆境胁迫、激素和信号物质的响应及对番茄的遗传转化;鞠立君;《中国优秀硕士学位论文全文数据库农业科技辑》;20180115;第1-9页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111575305A (en) | 2020-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111575305B (en) | Allene oxide synthetase, coding gene CsAOS and application thereof | |
CN110724696B (en) | Lipid hydroperoxide lyase and gene and application thereof | |
Ban et al. | Abscisic acid and 2, 4-dichlorophenoxyacetic acid affect the expression of anthocyanin biosynthetic pathway genes in ‘Kyoho’grape berries | |
CN111575254B (en) | Lipoxygenase, encoding gene CsLOX3 and application thereof | |
CN113122547B (en) | Application of CsMYB110 gene in regulation and control of carotenoid synthesis | |
Jadhav et al. | Expression analysis of key genes of phenylpropanoid pathway and phenol profiling during Ricinus communis–Fusarium oxysporum f. sp. ricini interaction | |
CN114774439B (en) | Tea tree CsFAAH6 gene and application thereof | |
EP3152228B1 (en) | Use of micropeptides in order to stimulate mycorrhizal symbiosis | |
CN113564181A (en) | Application of rape nucleotide triphosphate transporter gene BnNTT1 in regulation of oil content of crops | |
CN104694491B (en) | The anthocyanin reductase RrANR genes and its coding albumen of rose and application | |
Liu et al. | Transcriptome mining of genes in Zanthoxylum armatum revealed ZaMYB86 as a negative regulator of prickly development | |
CN114276959A (en) | Bacillus altitudinis and application thereof in improving cigar quality | |
CN112048515B (en) | Rape S-adenosine-L-methionine dependent methyltransferase gene BnPMT6 and application thereof | |
CN115948430B (en) | Pearl aldehyde dehydrogenase PusALDH1 and encoding gene and application thereof | |
CN114686493B (en) | CsJAZ12 gene and application thereof in regulating and controlling synthesis of tea caffeine | |
CN110305856A (en) | A kind of application of cytochrome P 450 enzymes | |
CN109593738A (en) | Gumbo herxheimer-liked reaction and anti reversion relative protein AePDS and its encoding gene and application | |
CN112694981B (en) | Candida zemplina strain YC32 of Candida zemplina and application thereof | |
CN110128517B (en) | Primula forbesii flower fragrance related gene PfLIS/NES and application thereof | |
CN112106652B (en) | Method for screening good variety of fragrant lotus flower fragrance | |
CN114711142A (en) | Chemical inducer for astragalus adventitious root tissue culture and application of chemical inducer in astragalus adventitious root culture | |
CN108795773A (en) | Moschus trichoderma strain and its fragrance of preparation | |
CN107653234B (en) | Zingiber officinale benzenoid type ester flower fragrance gene HcBSMT and application thereof | |
CN115074374B (en) | Apple triterpenic acid synthesis key enzyme genes MdTYP 716A2 and MdTYP 716C1 and application thereof | |
CN114990133B (en) | Tobacco carotenoid metabolism related gene and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220315 |